Literature DB >> 4053092

Structural studies of the capsular polysaccharide from Streptococcus pneumoniae type 5.

P E Jansson, B Lindberg, U Lindquist.   

Abstract

The structure of the capsular polysaccharide (S5) elaborated by Streptococcus pneumoniae type 5 has been investigated by using n.m.r. spectroscopy, methylation analysis, and various specific degradations. It is concluded that the polysaccharide is composed of pentasaccharide repeating-units having the following structure: (Formula: see text) In this structure, L-PneNAc stands for 2-acetamido-2,6-dideoxy-L-talose (pneumosamine) and D-Sug for 2-acetamido-2,6-dideoxy-D-xylo-hexos-4-ulose. The latter sugar accounts for the lability of S5 towards alkali. N.m.r. spectra indicate heterogeneity in S5, most probably associated with the hexosyl-4-ulose residue.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4053092     DOI: 10.1016/0008-6215(85)85053-9

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  10 in total

Review 1.  Immunogenicity and immunochemistry of Streptococcus pneumoniae capsular polysaccharides.

Authors:  J E van Dam; A Fleer; H Snippe
Journal:  Antonie Van Leeuwenhoek       Date:  1990-06       Impact factor: 2.271

2.  Effect of genetic switching of capsular type on virulence of Streptococcus pneumoniae.

Authors:  T Kelly; J P Dillard; J Yother
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

3.  Characterization of the structure and biological functions of a capsular polysaccharide produced by Staphylococcus saprophyticus.

Authors:  Sunny Park; Kathryn A Kelley; Evgeny Vinogradov; Robert Solinga; Christopher Weidenmaier; Yoshiki Misawa; Jean C Lee
Journal:  J Bacteriol       Date:  2010-07-16       Impact factor: 3.490

4.  Semisynthetic glycoconjugate vaccine candidate against Streptococcus pneumoniae serotype 5.

Authors:  Marilda P Lisboa; Naeem Khan; Christopher Martin; Fei-Fei Xu; Katrin Reppe; Andreas Geissner; Subramanian Govindan; Martin Witzenrath; Claney L Pereira; Peter H Seeberger
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-02       Impact factor: 11.205

Review 5.  The structural diversity of carbohydrate antigens of selected gram-negative marine bacteria.

Authors:  Evgeny L Nazarenko; Russell J Crawford; Elena P Ivanova
Journal:  Mar Drugs       Date:  2011-10-14       Impact factor: 6.085

6.  Molecular structure of endotoxins from Gram-negative marine bacteria: an update.

Authors:  Serena Leone; Alba Silipo; Evgeny L Nazarenko; Rosa Lanzetta; Michelangelo Parrilli; Antonio Molinaro
Journal:  Mar Drugs       Date:  2007-09-19       Impact factor: 5.118

7.  A physico-chemical assessment of the thermal stability of pneumococcal conjugate vaccine components.

Authors:  Fang Gao; Kay Lockyer; Karena Burkin; Dennis T Crane; Barbara Bolgiano
Journal:  Hum Vaccin Immunother       Date:  2014-11-17       Impact factor: 3.452

8.  Novel polysaccharide-protein conjugates provide an immunogenic 13-valent pneumococcal conjugate vaccine for S. pneumoniae.

Authors:  Allison E B Turner; Jonas E Gerson; Helen Y So; Daniel J Krasznai; Adrienne J St Hilaire; Donald F Gerson
Journal:  Synth Syst Biotechnol       Date:  2017-01-20

Review 9.  Purification of Capsular Polysaccharides of Streptococcus pneumoniae: Traditional and New Methods.

Authors:  Victor Morais; Valerie Dee; Norma Suárez
Journal:  Front Bioeng Biotechnol       Date:  2018-10-12

Review 10.  Recent Advances in the Synthesis of Glycoconjugates for Vaccine Development.

Authors:  Cinzia Colombo; Olimpia Pitirollo; Luigi Lay
Journal:  Molecules       Date:  2018-07-13       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.